Solasia Pharma: DARVIAS Injection 135mg Approved in Japan
19 Jun 2022 //
BUSINESSWIRE
Solasia, Nippon Kayaku Partner in Japan for DARINAPARSIN (SP-02)
26 Oct 2021 //
BUSINESSWIRE
Solasia announces the filing of a new regulatory filing for DARINAPARSIN
30 Jun 2021 //
BUSINESSWIRE
Solasia Announces Positive Results of DARINAPARSIN in Pivotal Phase 2 Study
14 Jun 2020 //
BUSINESSWIRE